Lindus Health, known for transforming clinical trials in the life sciences with faster and more dependable solutions, has announced that Dr. Paul Billings, a leading expert in diagnostics and genomic medicine, has joined its Scientific Advisory Board.
Health Technology Insights: Corti Achieves Surgical AI Breakthrough, Tops Interpretability Benchmark
Dr. Billings brings extensive experience from across the healthcare sector, including his leadership as Chairman and CEO of Biological Dynamics, where he advanced clinical applications of extracellular vesicles, and his role as Chief Medical Officer at Natera, a prominent company in genetic testing for oncology, women’s health, and organ function.
Health Technology Insights: ZOLL Launches Fifth-Generation LifeVest WCD
With more than 40 years of experience spanning academia, government, and industry, Dr. Billings will help guide Lindus Health’s strategic direction and support its mission to innovate clinical development. Meri Beckwith, Co-CEO of Lindus Health, said Dr. Billings’ expertise in diagnostics and genomics will be critical as the company broadens its collaborations with diagnostic innovators and continues to redefine how clinical trials are conducted. Dr. Billings expressed enthusiasm about joining the team, noting that diagnostic trials face unique challenges and that Lindus Health’s approach can overcome these barriers while creating more opportunities to improve patient outcomes.
This appointment comes as Lindus Health expands its presence across the United States, United Kingdom, and Europe, partnering with top pharmaceutical, biotechnology, diagnostic, medical device, and consumer health companies to accelerate clinical research through its comprehensive trial services and proprietary technology platform.
Health Technology Insights: Charlotte’s Web Joins Landmark Medicare and Medicaid CBD Pilot
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
